Study analysis · Nutrients · 2019
Eating nuts could add years to your life—but peanut butter won't help.
People who eat a small handful of nuts every day are 22% less likely to die over 15 years, but eating peanut butter doesn't make any difference.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study watched a huge group of people for over 15 years and noticed that those who ate more nuts tended to live longer. But it didn’t make them eat nuts — so we don’t know if the nuts themselves made the difference or if nut-eaters just had healthier habits overall.
What’s the bottom line?
People who ate more nuts like almonds or walnuts tended to live longer than those who didn't, but eating peanut butter didn't have the same effect.
How strong is this study?
This study is pretty strong because it followed so many people for a long time and used good records to track who died. But it’s not perfect — people had to remember what they ate, and we can’t be sure if nuts were the real reason for living longer or if other things like exercise or not smoking played a bigger role.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
56 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=566398)+20/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 567 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cohort study with no randomization or control of confounding variables. While associations are observed, factors like lifestyle, diet, and socioeconomic status may explain the results rather than nut consumption directly causing changes in mortality.
No Conflicts
No conflicts of interest identified
No conflicts of interest were disclosed, and the study was funded by a government agency with no evidence of industry influence or author financial ties.
Funders
Conflict Details
National Institutes of Health (NIH): Funding provided for the NIH-AARP Diet and Health Study
Independent Analysis Safeguards
- Statistical analysis conducted using STATA software with adjustment for multiple confounders
- Sensitivity analyses excluding first two years of follow-up
- Use of validated food-frequency questionnaire and nutrient database
- Proportional hazards assumption tested via Schoenfeld residuals
The study was conducted by a large, well-established government-funded cohort with no disclosed industry funding, author affiliations with commercial entities, or evidence of funder control over methodology or reporting. Results appear methodologically rigorous and unbiased.
Key takeaways
- 01
People who ate at least 2.15 grams of nuts per day had a 22% lower chance of dying from any cause over 15.5 years.
- 02
Peanut butter eaters had no lower risk of death.
- 03
Yes — eating a small handful of nuts daily may help you live longer, especially from heart disease or cancer, but peanut butter doesn't seem to help.
Surprising findings
- Peanut butter consumption showed no mortality benefit despite being made from peanuts, which are technically legumes often grouped with nuts.Most people assume peanut butter is nutritionally equivalent to whole nuts—this study proves it’s not, even when intake levels are similar.
- Nut consumption was linked to lower death risk from respiratory and liver diseases—two causes rarely studied in nutrition research.Most nutrition studies focus on heart disease and cancer. This study found nuts may protect against rarer but deadly conditions like liver cirrhosis and lung disease.
Practical takeaways
Swap your morning peanut butter toast for a small handful (about 1 oz or 28g) of raw or dry-roasted almonds, walnuts, or cashews.
This study only shows association—not causation—and benefits were seen in middle-aged U.S. adults. Results may not apply to children or non-U.S. populations.
medium confidenceIf you love peanut butter, choose natural varieties with no added sugar or hydrogenated oils—but don’t expect it to extend your life like whole nuts.
Peanut butter eaters in the study had worse lifestyle habits overall, so the problem may be what they eat with it—not the peanut butter itself.
low confidenceWhy this study matters
Nuts = Longer Life
People who ate at least 2.15 grams of nuts per day (about a small handful) had a 22% lower risk of dying from any cause over 15.5 years, according to a study of 374,101 middle-aged U.S. adults. This reduction held even after adjusting for smoking, BMI, exercise, and other diet factors.
It’s rare to find a food that’s this strongly linked to living longer—and it’s something you can easily add to your daily routine without drastic lifestyle changes.
Peanut Butter Is a Red Herring
Despite similar consumption levels, peanut butter showed zero association with reduced mortality (HR = 1.00, 95% CI: 0.98–1.04). Peanut butter eaters were more likely to smoke, have higher BMI, and eat more red meat—suggesting lifestyle factors may cancel out any potential benefits.
Everyone assumes peanut butter is just ‘crushed nuts’—but this study proves it’s not the same. This could change how people think about their morning toast.
It Doesn't Help With Diabetes or Alzheimer’s
While nuts lowered death risk from heart disease, cancer, and liver disease, they showed no protective effect against death from diabetes or Alzheimer’s disease—two conditions people often assume diet can prevent.
This challenges the popular narrative that 'healthy foods fix everything.' It shows diet has limits—and that’s scientifically important.
The 2-Year Rule Proves It’s Not Reverse Causation
Researchers excluded people who died in the first two years of the study to rule out the idea that sick people just ate fewer nuts. The 22% benefit remained—strong evidence nuts aren’t just a side effect of being healthy.
Most observational studies get dismissed because 'sick people eat less.' This one actively tested that—and still found the link.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
People who ate more nuts like almonds or walnuts tended to live longer than those who didn't, but eating peanut butter didn't have the same effect.
Research results
People who ate at least 2.15 grams of nuts per day had a 22% lower chance of dying from any cause over 15.5 years. Peanut butter eaters had no lower risk of death.
What this means - more context
Yes — eating a small handful of nuts daily may help you live longer, especially from heart disease or cancer, but peanut butter doesn't seem to help.
This study investigates whether nut and peanut butter consumption are associated with all-cause and cause-specific mortality in a large U.S. middle-aged cohort.
Higher nut consumption (≥2.15 g/day) was associated with a 22% lower risk of all-cause mortality and reduced mortality from cardiovascular disease, cancer, respiratory, infectious, renal, and liver diseases, but not diabetes or Alzheimer’s. Peanut butter consumption showed no significant association with any mortality outcome.
Methods Used
Prospective cohort study of 374,101 middle-aged U.S. adults followed for 15.5 years; nut and peanut butter intake assessed via food-frequency questionnaire; hazard ratios estimated using Cox proportional hazards models adjusted for age, sex, smoking, BMI, physical activity, and dietary factors.
Main Finding
Nut consumption ≥2.15 g/day was associated with a 22% lower risk of all-cause mortality (HR = 0.78, 95% CI: 0.76–0.81); no significant association was found for peanut butter consumption (HR = 1.00, 95% CI: 0.98–1.04).
Confidence Level
Moderate to high; large sample size, long follow-up, adjustment for multiple confounders, and sensitivity analysis excluding early follow-up reduce bias, but residual confounding and self-reported diet remain limitations.
Study Flags
Red Flags
- •Self-reported dietary intake
- •Potential residual confounding by lifestyle factors
- •Limited generalizability to younger or non-U.S. populations
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Peanut butter consumption showed no mortality benefit despite being made from peanuts, which are technically legumes often grouped with nuts.
Most people assume peanut butter is nutritionally equivalent to whole nuts—this study proves it’s not, even when intake levels are similar.
Practical Takeaways
Swap your morning peanut butter toast for a small handful (about 1 oz or 28g) of raw or dry-roasted almonds, walnuts, or cashews.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 567 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study watched a huge group of people for over 15 years and noticed that those who ate more nuts tended to live longer. But it didn’t make them eat nuts — so we don’t know if the nuts themselves made the difference or if nut-eaters just had healthier habits overall.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Very large sample size (n=566,398)
- Long follow-up period (median 15.5 years)
- Accurate mortality ascertainment via Death Master File
Weaknesses
- Observational design — no randomization
- Self-reported dietary intake — prone to recall and reporting bias
- Single baseline dietary assessment — does not capture changes over time
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
People who ate more nuts like almonds or walnuts tended to live longer than those who didn't, but eating peanut butter didn't have the same effect.
Research results
People who ate at least 2.15 grams of nuts per day had a 22% lower chance of dying from any cause over 15.5 years. Peanut butter eaters had no lower risk of death.
What this means - more context
Yes — eating a small handful of nuts daily may help you live longer, especially from heart disease or cancer, but peanut butter doesn't seem to help.
This study investigates whether nut and peanut butter consumption are associated with all-cause and cause-specific mortality in a large U.S. middle-aged cohort.
Higher nut consumption (≥2.15 g/day) was associated with a 22% lower risk of all-cause mortality and reduced mortality from cardiovascular disease, cancer, respiratory, infectious, renal, and liver diseases, but not diabetes or Alzheimer’s. Peanut butter consumption showed no significant association with any mortality outcome.
Methods Used
Prospective cohort study of 374,101 middle-aged U.S. adults followed for 15.5 years; nut and peanut butter intake assessed via food-frequency questionnaire; hazard ratios estimated using Cox proportional hazards models adjusted for age, sex, smoking, BMI, physical activity, and dietary factors.
Main Finding
Nut consumption ≥2.15 g/day was associated with a 22% lower risk of all-cause mortality (HR = 0.78, 95% CI: 0.76–0.81); no significant association was found for peanut butter consumption (HR = 1.00, 95% CI: 0.98–1.04).
Confidence Level
Moderate to high; large sample size, long follow-up, adjustment for multiple confounders, and sensitivity analysis excluding early follow-up reduce bias, but residual confounding and self-reported diet remain limitations.
Study Flags
Red Flags
- •Self-reported dietary intake
- •Potential residual confounding by lifestyle factors
- •Limited generalizability to younger or non-U.S. populations
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Peanut butter consumption showed no mortality benefit despite being made from peanuts, which are technically legumes often grouped with nuts.
Most people assume peanut butter is nutritionally equivalent to whole nuts—this study proves it’s not, even when intake levels are similar.
Practical Takeaways
Swap your morning peanut butter toast for a small handful (about 1 oz or 28g) of raw or dry-roasted almonds, walnuts, or cashews.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 567 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study watched a huge group of people for over 15 years and noticed that those who ate more nuts tended to live longer. But it didn’t make them eat nuts — so we don’t know if the nuts themselves made the difference or if nut-eaters just had healthier habits overall.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Very large sample size (n=566,398)
- Long follow-up period (median 15.5 years)
- Accurate mortality ascertainment via Death Master File
Weaknesses
- Observational design — no randomization
- Self-reported dietary intake — prone to recall and reporting bias
- Single baseline dietary assessment — does not capture changes over time
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study is pretty strong because it followed so many people for a long time and used good records to track who died. But it’s not perfect — people had to remember what they ate, and we can’t be sure if nuts were the real reason for living longer or if other things like exercise or not smoking played a bigger role.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
56 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=566398)+20/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 567 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cohort study with no randomization or control of confounding variables. While associations are observed, factors like lifestyle, diet, and socioeconomic status may explain the results rather than nut consumption directly causing changes in mortality.
No Conflicts
No conflicts of interest identified
No conflicts of interest were disclosed, and the study was funded by a government agency with no evidence of industry influence or author financial ties.
Funders
Conflict Details
National Institutes of Health (NIH): Funding provided for the NIH-AARP Diet and Health Study
Independent Analysis Safeguards
- Statistical analysis conducted using STATA software with adjustment for multiple confounders
- Sensitivity analyses excluding first two years of follow-up
- Use of validated food-frequency questionnaire and nutrient database
- Proportional hazards assumption tested via Schoenfeld residuals
The study was conducted by a large, well-established government-funded cohort with no disclosed industry funding, author affiliations with commercial entities, or evidence of funder control over methodology or reporting. Results appear methodologically rigorous and unbiased.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Physionic cite this study, drawing 1 claim from it.
- Very strong evidencePeople who eat nuts have a lower rate of death from any cause compared to those who do not eat nuts.
Randomized or controlled trials support this claim, alongside consistent supporting evidence.
Evidence
Authored by
6 researchersIf this is your work, this is how we attribute it on Fit Body Science. Vineeth Amba is listed as the lead author.